Veterinary Medicines

DECTOMAX 10 mg/ml Solution for Injection for Cattle, Sheep and Pigs

Authorised
  • Doramectin
Download as PDF

Product identification

Medicine name:
DECTOMAX 10 mg/ml Solution for Injection for Cattle, Sheep and Pigs
Dectomax, 10 mg/ml süstelahus veistele, lammastele ja sigadele
Active substance:
  • Doramectin
Target species:
  • Sheep
  • Pig
  • Cattle
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Doramectin
    10.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Sheep
      • Meat and offal
        70
        day
    • Pig
      • Meat and offal
        77
        day
  • Subcutaneous use
    • Cattle
      • Meat and offal
        70
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP54AA03
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Estonia
Package description:
  • Available only in Estonian
  • Available only in Estonian
  • Available only in Estonian
  • Available only in Estonian
  • The product is supplied in 50 ml multi-dose Type III amber glass vials with chlorobutyl rubber stoppers and aluminium overcaps.
  • The product is supplied in 200 ml multi-dose Type III amber glass vials with chlorobutyl rubberstoppers and aluminium overcaps.
  • The product is supplied in 500 ml multi-dose Type III amber glass vials with chlorobutyl rubber stoppers and aluminium overcaps.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Zoetis Belgium
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
  • Zoetis Manufacturing & Research Spain S.L.
Responsible authority:
  • State Agency Of Medicines
Authorisation number:
  • 1740
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0260/001
Concerned member states:
  • Austria
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Estonia
  • France
  • Greece
  • Hungary
  • Latvia
  • Lithuania
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Spain

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download
Estonian (PDF)
Published on: 14/02/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."